Skip to main content
Top
Published in: Inflammation 5/2014

01-10-2014

sHLA-G Involved in the Apoptosis of Decidual Natural Killer Cells Following Toxoplasma gondii Infection

Authors: Meiyu Han, Yuzhu Jiang, Kaixue Lao, Xiaoyan Xu, Shaowei Zhan, Yanlin Wang, Xuemei Hu

Published in: Inflammation | Issue 5/2014

Login to get access

Abstract

This study aims to assess whether soluble HLA-G (sHLA-G) is involved in apoptosis of decidual natural killer (dNK) cells following Toxoplasma gondii infection. dNK cells or NK-92 cells were infected with T. gondii and co-cultured with trophoblast cells or BeWo cells. Infected co-cultured cells were treated without or with sHLA-G neutralizing antibody. Uninfected co-cultured cells were used as controls. Apoptosis of dNK cells were analyzed by flow cytometry and confocal microscope. Real-time PCR and Western blot were used to determine caspase 3 and caspase 8 expression. sHLA-G in supernatant were measured by enzyme-linked immunosorbent assay (ELISA). In infection groups, sHLA-G was increased, while dNK apoptosis proteins caspase 3 and caspase 8 were up-regulated, but significantly decreased in the presence of sHLA-G neutralizing antibody compared to controls. Under the situation of T. gondii-infected dNK cells co-cultured with trophoblast cells, the up-regulation of sHLA-G could induce dNK cells apoptosis which ultimately may contribute to the abnormal pregnancy outcomes with T. gondii infection.
Literature
2.
go back to reference Robbins, J.R., V.B. Zeldovich, A. Poukchanski, J.C. Boothroyd, and A.I. Bakardjiev. 2012. Tissue barriers the human placenta to infection with Toxoplasma gondii. Infection and Immunity 80: 418–428.PubMedCrossRefPubMedCentral Robbins, J.R., V.B. Zeldovich, A. Poukchanski, J.C. Boothroyd, and A.I. Bakardjiev. 2012. Tissue barriers the human placenta to infection with Toxoplasma gondii. Infection and Immunity 80: 418–428.PubMedCrossRefPubMedCentral
3.
go back to reference Cecati, M., S.R. Giannubilo, M. Emanuelli, A.L. Tranquilli, and F. Saccucci. 2011. HLA-G and pregnancy adverse outcomes. Medical Hypotheses 76: 782–784.PubMedCrossRef Cecati, M., S.R. Giannubilo, M. Emanuelli, A.L. Tranquilli, and F. Saccucci. 2011. HLA-G and pregnancy adverse outcomes. Medical Hypotheses 76: 782–784.PubMedCrossRef
4.
go back to reference Rizzo, R., A.S. Andersen, M.R. Lassen, H.C. Sørensen, T. Bergholt, M.H. Larsen, L. Melchiorri, M. Stignani, O.R. Baricordi, and T.V. Hviid. 2009. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. American Journal of Reproductive Immunology 62: 320–338.PubMedCrossRef Rizzo, R., A.S. Andersen, M.R. Lassen, H.C. Sørensen, T. Bergholt, M.H. Larsen, L. Melchiorri, M. Stignani, O.R. Baricordi, and T.V. Hviid. 2009. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. American Journal of Reproductive Immunology 62: 320–338.PubMedCrossRef
5.
go back to reference Fuji, T., A. Ishitani, and D.E. Geraghty. 1994. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology 153: 5516–5524. Fuji, T., A. Ishitani, and D.E. Geraghty. 1994. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology 153: 5516–5524.
6.
go back to reference Paul, P., F.A. Cabestre, E.C. Ibrahim, S. Lefebvre, I. Khalil-Daher, G. Vazeux, et al. 2000. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6 and -G7 transcripts in human transfected cells. Human Immunology 61: 1138–4.PubMedCrossRef Paul, P., F.A. Cabestre, E.C. Ibrahim, S. Lefebvre, I. Khalil-Daher, G. Vazeux, et al. 2000. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6 and -G7 transcripts in human transfected cells. Human Immunology 61: 1138–4.PubMedCrossRef
7.
go back to reference Carosella, E.D., P. Moreau, J. Le Maoult, M. Le’Discorde, J. Dausset, and N. Rouass-Freiss. 2003. HLA-G molecules: from maternal–fetal tolerance to tissue acceptance. Advances in Immunology 81: 199–252.PubMedCrossRef Carosella, E.D., P. Moreau, J. Le Maoult, M. Le’Discorde, J. Dausset, and N. Rouass-Freiss. 2003. HLA-G molecules: from maternal–fetal tolerance to tissue acceptance. Advances in Immunology 81: 199–252.PubMedCrossRef
8.
go back to reference O’Brien, M., J. Dausset, E.D. Carosella, and P. Moreau. 2000. Analysis of the role of HLA-G in preeclampsia. Human Immunology 61: 1126–1131.PubMedCrossRef O’Brien, M., J. Dausset, E.D. Carosella, and P. Moreau. 2000. Analysis of the role of HLA-G in preeclampsia. Human Immunology 61: 1126–1131.PubMedCrossRef
9.
go back to reference Ponte, M., C. Cantoni, R. Biassoni, L. Moretta, M.C. Mingari, et al. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proceedings of the National Academy of Sciences of the United States of America 96: 5674–5679.PubMedCrossRefPubMedCentral Ponte, M., C. Cantoni, R. Biassoni, L. Moretta, M.C. Mingari, et al. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proceedings of the National Academy of Sciences of the United States of America 96: 5674–5679.PubMedCrossRefPubMedCentral
10.
go back to reference Carosella, E.D., P. Moreau, S. Aractingi, and N. Rouas-Freiss. 2001. HLA-G: a shield against inflammatory aggression. Trends in Immunology 22: 553–555.PubMedCrossRef Carosella, E.D., P. Moreau, S. Aractingi, and N. Rouas-Freiss. 2001. HLA-G: a shield against inflammatory aggression. Trends in Immunology 22: 553–555.PubMedCrossRef
11.
go back to reference Yie, S.M., L.H. Li, Y.M. Li, and C. Librach. 2004. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. American Journal of Obstetrics and Gynecology 191: 525–529.PubMedCrossRef Yie, S.M., L.H. Li, Y.M. Li, and C. Librach. 2004. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. American Journal of Obstetrics and Gynecology 191: 525–529.PubMedCrossRef
12.
go back to reference Hackmon, R., A. Koifman, H. Hyodo, H. Glickman, E. Sheiner, and D.E. Geraghty. 2007. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. American Journal of Obstetrics and Gynecology 97(255): e1–e5. Hackmon, R., A. Koifman, H. Hyodo, H. Glickman, E. Sheiner, and D.E. Geraghty. 2007. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. American Journal of Obstetrics and Gynecology 97(255): e1–e5.
13.
go back to reference Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nature Reviews Immunology 6: 584–594.PubMedCrossRef Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nature Reviews Immunology 6: 584–594.PubMedCrossRef
14.
go back to reference Bulmer, J.N., P.J. Williams, and G.E. Lash. 2010. Immune cells in the placental bed. International Journal of Developmental Biology 54: 281–294.PubMedCrossRef Bulmer, J.N., P.J. Williams, and G.E. Lash. 2010. Immune cells in the placental bed. International Journal of Developmental Biology 54: 281–294.PubMedCrossRef
15.
go back to reference Santoni, A., A. Zingoni, C. Cerboni, and A. Gismondi. 2007. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. American Journal of Reproductive Immunology 58: 280–288.PubMedCrossRef Santoni, A., A. Zingoni, C. Cerboni, and A. Gismondi. 2007. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. American Journal of Reproductive Immunology 58: 280–288.PubMedCrossRef
16.
go back to reference Saito, S., K. Nishikawa, T. Morii, M. Enomoto, N. Narita, K. Motoyoshi, and M. Ichijo. 1993. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. International Immunology 5: 559–563.PubMedCrossRef Saito, S., K. Nishikawa, T. Morii, M. Enomoto, N. Narita, K. Motoyoshi, and M. Ichijo. 1993. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. International Immunology 5: 559–563.PubMedCrossRef
17.
go back to reference Lindaman, A., A. Dowden, and N. Zavazava. 2006. Soluble HLA-G molecules induce apoptosis in natural killer cells. American Journal of Reproductive Immunology 56: 68–76.PubMedCrossRef Lindaman, A., A. Dowden, and N. Zavazava. 2006. Soluble HLA-G molecules induce apoptosis in natural killer cells. American Journal of Reproductive Immunology 56: 68–76.PubMedCrossRef
19.
20.
go back to reference Manaster, I., and O. Mandelboim. 2008. The unique properties of human NK cells in the uterine mucosa. Placenta 29: S60–S66.PubMedCrossRef Manaster, I., and O. Mandelboim. 2008. The unique properties of human NK cells in the uterine mucosa. Placenta 29: S60–S66.PubMedCrossRef
21.
go back to reference Hanna, J., and O. Mandelboim. 2007. When killers become helpers. Trends in Immunology 28: 201–206.PubMedCrossRef Hanna, J., and O. Mandelboim. 2007. When killers become helpers. Trends in Immunology 28: 201–206.PubMedCrossRef
22.
go back to reference Persson, C.M., H. Lambert, P.P. Vutova, I. Dellacasa-Lindberg, J. Nederby, H. Yagita, H.G. Ljunggren, A. Grandien, A. Barragan, and B.J. Chambers. 2009. Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infection and Immunity 77: 970–976.PubMedCrossRefPubMedCentral Persson, C.M., H. Lambert, P.P. Vutova, I. Dellacasa-Lindberg, J. Nederby, H. Yagita, H.G. Ljunggren, A. Grandien, A. Barragan, and B.J. Chambers. 2009. Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infection and Immunity 77: 970–976.PubMedCrossRefPubMedCentral
23.
go back to reference Solier, C., M. Aguerre-Girr, F. Lenfant, A. Campan, A. Berrebi, V. Rebmann, H. Grosse-Wilde, and P. Le Bouteiller. 2002. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. European Journal of Immunology 32: 3576–3586.PubMedCrossRef Solier, C., M. Aguerre-Girr, F. Lenfant, A. Campan, A. Berrebi, V. Rebmann, H. Grosse-Wilde, and P. Le Bouteiller. 2002. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. European Journal of Immunology 32: 3576–3586.PubMedCrossRef
24.
go back to reference Rebmann, V., K. Pfeiffer, M. Pässler, S. Ferrone, S. Maier, E. Weiss, and H. Grosse-Wilde. 1999. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53: 14–22.PubMedCrossRef Rebmann, V., K. Pfeiffer, M. Pässler, S. Ferrone, S. Maier, E. Weiss, and H. Grosse-Wilde. 1999. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53: 14–22.PubMedCrossRef
25.
go back to reference Jassem, R.M., W.S. Shani, D.A. Loisel, M. Sharief, C. Billstrand, and C. Ober. 2012. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Human Immunology 73: 811–817.PubMedCrossRefPubMedCentral Jassem, R.M., W.S. Shani, D.A. Loisel, M. Sharief, C. Billstrand, and C. Ober. 2012. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq. Human Immunology 73: 811–817.PubMedCrossRefPubMedCentral
26.
go back to reference Zavazava, N. 1998. Soluble HLA, class I molecules: biological significance and clinical implications. Molecular Medicine Today 4: 116–121.PubMedCrossRef Zavazava, N. 1998. Soluble HLA, class I molecules: biological significance and clinical implications. Molecular Medicine Today 4: 116–121.PubMedCrossRef
27.
go back to reference Le Bouteiller, P. 2004. The role of HLA-G expression in the embryo during implantation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris) 33: S9–S12.CrossRef Le Bouteiller, P. 2004. The role of HLA-G expression in the embryo during implantation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris) 33: S9–S12.CrossRef
28.
go back to reference Nagata, S. 1994. Fas and Fas ligand: a death factor and its receptor. Advances in Immunology 57: 129–144.PubMedCrossRef Nagata, S. 1994. Fas and Fas ligand: a death factor and its receptor. Advances in Immunology 57: 129–144.PubMedCrossRef
29.
go back to reference Peter, M.E., F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.M. Debatin, and P.H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase-8) to the CD95 death-inducing signaling complex. European Journal of Immunology 27: 1207–1212.PubMedCrossRef Peter, M.E., F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.M. Debatin, and P.H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase-8) to the CD95 death-inducing signaling complex. European Journal of Immunology 27: 1207–1212.PubMedCrossRef
Metadata
Title
sHLA-G Involved in the Apoptosis of Decidual Natural Killer Cells Following Toxoplasma gondii Infection
Authors
Meiyu Han
Yuzhu Jiang
Kaixue Lao
Xiaoyan Xu
Shaowei Zhan
Yanlin Wang
Xuemei Hu
Publication date
01-10-2014
Publisher
Springer US
Published in
Inflammation / Issue 5/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9900-7

Other articles of this Issue 5/2014

Inflammation 5/2014 Go to the issue